CpG methylation of HPV 16 LCR at E2 binding site proximal to P97 is associated with cervical cancer in presence of intact E2

Virology

Volumn 354, Issue 2, 2006, Pages 280-285

  Bhattacharjee, Bornali ^a   Sengupta, Sharmila ^a  

^a INDIAN STATISTICAL INSTITUTE   (India)

Author keywords

Cervical cancer; E2 binding site; HPV16 genome methylation; Intact E2 gene

Indexed keywords

PROTEIN E2; PROTEIN P97; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; BINDING SITE; CPG ISLAND; CYTOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; METHYLATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RANDOMIZATION; STATISTICAL SIGNIFICANCE; UTERINE CERVIX CANCER;

ADULT; BINDING SITES; CPG ISLANDS; DNA METHYLATION; DNA, VIRAL; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, VIRAL; GENOME, VIRAL; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 6; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 33749537658     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.06.018     Document Type: Article

References (12)

1. Badal V., Chuang L.S.H., Tan E.H.-H., et al. CpG methylation of human papillomavirus type 16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression. J. Virol. 77 (2003) 6227-6234
2. Bhattacharjee B., and Sengupta S. HPV16 E2 gene disruption and polymorphisms of E2 and LCR: some significant associations with cervical cancer in Indian women. Gynecol. Oncol. 100 (2006) 372-378
3. Cullen A.P., Reid R., and Lorincz A.T. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive neoplasm. J. Virol. 65 (1991) 606-612
4. Herman J.G., Graff J.R., Myohanen S., Nelkin B.D., and Baylin S.B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 9821-9826
5. Jeon S., and Lambert P.F. Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 1654-1658
6. Kalantari M., Macias I.E.C., Tewari D., et al. Conserved methylation patterns of human papillomavirus type 16 DNA in asymptomatic infection and cervical neoplasia. J. Virol. 78 (2004) 12762-12772
7. Kim K., Hamrick P.A.G., Fisher C., Lee D., and Lambert P.F. Methylation patterns of papillomavirus DNA, its influence on E2 function, and implications in viral infection. J. Virol. 77 (2003) 12450-12459
8. Lukaszuk K., Liss J., Wozniak I., Emerich J., and Wojcikowski C. Human papillomavirus type 16 status in cervical carcinoma cell DNA assayed by multiplex PCR. J. Clin. Microbiol. 41 (2003) 608-612
9. Matsukura T., Koi S., and Sugase M. Both episomal and integrated forms of human papillomavirus type 16 are involved in invasive cervical cancers. Virology 172 (1989) 63-72
10. Tan S.-H., Leong L.E.-C., Walker P.A., and Bernard H.-U. The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID. J. Virol. 68 (1994) 6411-6420
11. Thain A., Jenkins O., Clarke A.R., and Gaston K. CpG methylation directly inhibits binding of the human papillomavirus type 16 E2 protein to specific DNA sequences. J. Virol. 70 (1996) 7233-7235
12. Tornesello M.L., Buonaguro F.M., Buonaguro L., Salatiello I., Giraldo E.B., and Giraldo G. Identification and functional analysis of sequence rearrangements in the long control region of human papillomavirus type 16 Af-1 variants isolated from Ugandan penile carcinomas. J. Gen. Virol. 81 (2000) 2969-2982